Concern pharmacists are calling for more strict penalties for those involved in distributing counterfeit and illicit drugs in Nigeria. The demand for strict punishment follows rising concerns over the effects that fake medicines have on public health. Many believe that existing penalties are insufficient and fail to effectively prevent drug dealers. The National Agency for Food and Drug Administration and Control (NAFDAC) recently seized over 100 truckloads of fake and banned medicines in major markets across Lagos, Onitsha, and Aba.
As a result, these substandard products pose a serious threat to millions of Nigerians, as they can cause severe health complications and even death in some cases. Amid growing public outcry, pharmacists are advocating for life imprisonment for those found guilty, arguing that stronger measures are necessary to curb the menace. Currently, offenders convicted under Nigeria’s Counterfeit and Fake Drugs (Miscellaneous Provisions) Act face a fine of ₦500,000 or a maximum of five years in prison. Pharmacists argue that these penalties are far too lenient and fail to deter criminal networks from engaging in the illicit trade.
Health risks of fake medicine necessitate urgent action.
In comparison, many other countries impose stricter punishments, making Nigeria a prime target for traffickers looking for weak regulatory enforcement. The continued presence of fake products in the country has led to increased mortality rates, resistance, and a lack of confidence in the healthcare system. Many Nigerians unknowingly purchase and consume fake medicines, believing them to be legitimate. In cases where fake products replace essential medicines for life-threatening conditions like malaria, tuberculosis, and HIV/AIDS, the consequences can be fatal.
Furthermore, its impact extends beyond individual patients, affecting the entire healthcare system and the economy. These fake medicines often contain the wrong ingredients, no active ingredients, or insufficient amounts of active substances, leading to ineffective treatment and worsening health conditions. When patients rely on substandard products, diseases that could have been treated easily become more difficult to manage, resulting in prolonged illnesses and avoidable deaths. NAFDAC has repeatedly warned that the presence of falsified medicines in circulation could lead to a national health crisis if left unchecked.
Stronger law enforcement is needed to combat counterfeit drugs.
However, the agency continues to intensify efforts to remove fake products from the market, but regulatory loopholes and the high profitability of the illegal Trade make enforcement challenging. They believe that implementing life imprisonment for offenders will reduce the circulation of these dangerous substances by instilling fear in those who profit from the illegal market. One key issue contributing to the prevalence of fake products is the weakness of Nigeria’s regulatory framework. Open drug markets, corruption, and inadequate enforcement make it easy for fake medicines to flood the market.
Additionally, Nigeria’s heavy reliance on imported pharmaceuticals increases the risk of counterfeit products entering the country through unregulated channels. The problem is unlikely to be resolved without stronger laws and better enforcement. Pharmacists are urging the government to implement reforms that will make its related offences a top priority. Life imprisonment for traffickers, they argue, would not only incapacitate those responsible but also serve as a warning to others involved in the illicit trade. Stricter regulations, increased surveillance of Medicine supply chains, and enhanced penalties are necessary to address the crisis effectively.
Related Article: NAFDAC issues alert on falsified Cikatem drug
While harsher penalties are essential in combating fake medicine, the emphasis is on public awareness. Many Nigerians are unaware of the risks associated with buying drugs from unregulated sources. Without adequate knowledge, consumers continue to purchase medications from open markets and unauthorised sellers, unknowingly putting their lives at risk. Government agencies, healthcare professionals, and Civil Society organisations must work together to educate the public on how to identify genuine medicines and where to access safe pharmaceuticals.